Growth Metrics

Acadia Pharmaceuticals (ACAD) Shareholder's Equity (QoQ) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 Acadia Pharmaceuticals 3.69 Bn 2.84 Bn 243.27 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 1.68%
Dec 31, 2025 33.81%
Sep 30, 2025 11.54%
Jun 30, 2025 7.47%
Mar 31, 2025 4.43%
Dec 31, 2024 26.96%
Sep 30, 2024 11.71%
Jun 30, 2024 11.35%
Mar 31, 2024 7.48%
Dec 31, 2023 19.21%
Sep 30, 2023 -8.49%
Jun 30, 2023 5.75%
Mar 31, 2023 -6.53%
Dec 31, 2022 -5.94%
Sep 30, 2022 -2.11%
Jun 30, 2022 -2.24%
Mar 31, 2022 -17.77%
Dec 31, 2021 -4.60%
Sep 30, 2021 0.37%
Jun 30, 2021 -2.88%
Mar 31, 2021 -7.24%
Dec 31, 2020 -4.25%
Sep 30, 2020 -1.23%
Jun 30, 2020 3.86%
Mar 31, 2020 -8.69%
Dec 31, 2019 1.43%
Sep 30, 2019 77.23%
Jun 30, 2019 -7.04%
Mar 31, 2019 -12.67%
Dec 31, 2018 114.41%
Sep 30, 2018 -15.59%
Jun 30, 2018 -12.97%
Mar 31, 2018 -9.28%
Dec 31, 2017 -11.14%
Sep 30, 2017 -9.11%
Jun 30, 2017 -9.26%
Mar 31, 2017 -11.74%
Dec 31, 2016 -10.32%
Sep 30, 2016 41.40%
Jun 30, 2016 -8.18%
Mar 31, 2016 122.89%
Dec 31, 2015 -12.13%
Sep 30, 2015 -11.13%
Jun 30, 2015 -10.27%
Mar 31, 2015 -7.88%
Dec 31, 2014 -6.35%
Sep 30, 2014 -5.60%
Jun 30, 2014 -4.20%
Mar 31, 2014 100.66%
Dec 31, 2013 0.76%
Sep 30, 2013 -0.40%
Jun 30, 2013 127.81%
Mar 31, 2013 -6.26%
Dec 31, 2012 381.11%
Sep 30, 2012 39.00%
Jun 30, 2012 -27.73%
Mar 31, 2012 -24.73%
Dec 31, 2011 -16.99%
Sep 30, 2011 -14.25%